These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 28342193

  • 1. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn , and LC-HR-MS/MS.
    Caspar AT, Gaab JB, Michely JA, Brandt SD, Meyer MR, Maurer HH.
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
    Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH.
    Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
    [Abstract] [Full Text] [Related]

  • 3. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS.
    Michely JA, Brandt SD, Meyer MR, Maurer HH.
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [Abstract] [Full Text] [Related]

  • 4. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".
    A Michely JA, Manier SK, Caspar AT, Brandt SD, Wallach J, Maurer HH.
    Curr Neuropharmacol; 2017 Feb; 15(5):692-712. PubMed ID: 27758707
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT, Helfer AG, Michely JA, Auwärter V, Brandt SD, Meyer MR, Maurer HH.
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MSn , and LC-HR-MSn.
    Wink CS, Michely JA, Jacobsen-Bauer A, Zapp J, Maurer HH.
    Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
    [Abstract] [Full Text] [Related]

  • 10. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
    Meyer MR, Holderbaum A, Kavanagh P, Maurer HH.
    J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
    [Abstract] [Full Text] [Related]

  • 11. Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn.
    Welter J, Meyer MR, Kavanagh P, Maurer HH.
    Anal Bioanal Chem; 2014 Mar; 406(7):1957-74. PubMed ID: 24452743
    [Abstract] [Full Text] [Related]

  • 12. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
    Vorce SP, Sklerov JH.
    J Anal Toxicol; 2004 Sep; 28(6):407-10. PubMed ID: 15516287
    [Abstract] [Full Text] [Related]

  • 13. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
    Wagmann L, Hempel N, Richter LHJ, Brandt SD, Stratford A, Meyer MR.
    Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
    [Abstract] [Full Text] [Related]

  • 14. Development of an LC-MS/MS method for determining 5-MeO-DIPT in dried urine spots and application to forensic cases.
    Yan X, Yuan S, Yu Z, Zhao Y, Zhang S, Wu H, Yan H, Xiang P.
    J Forensic Leg Med; 2020 May; 72():101963. PubMed ID: 32452453
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.
    Brandt SD, Kavanagh PV, Dowling G, Talbot B, Westphal F, Meyer MR, Maurer HH, Halberstadt AL.
    Drug Test Anal; 2017 Jan; 9(1):115-126. PubMed ID: 27100373
    [Abstract] [Full Text] [Related]

  • 18. GC-MS and LC-(high-resolution)-MS(n) studies on the metabolic fate and detectability of camfetamine in rat urine.
    Welter J, Kavanagh P, Maurer HH.
    Anal Bioanal Chem; 2014 Jun; 406(16):3815-29. PubMed ID: 24828975
    [Abstract] [Full Text] [Related]

  • 19. Determination of 5-MeO-DIPT in Human Urine Using Gas Chromatography Coupled with High-Resolution Orbitrap Mass Spectrometry.
    Yan X, Xiang P, Zhao Y, Yu Z, Yan H.
    J Anal Toxicol; 2020 Apr 02; 44(5):461-469. PubMed ID: 32020169
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.